- Study of 13,905 patients with inflammatory arthritis.
- Impaired fasting glucose or sulfonylureas linked to higher risk of major adverse cardiovascular events.
- Elevated glucose levels associated with increased cardiovascular risks.
- Importance of proactive glucose management highlighted.
- Need for careful selection of antidiabetic treatments in this patient population.
- Proactive glucose monitoring and early blood glucose control may play a crucial role in preventing cardiovascular disease among patients with inflammatory arthritis.
- Emphasizing the need for proactive glucose management and antidiabetic treatments.
- Limitations include lack of data on lifestyle risk factors.
Source: Diabetology & Metabolic Syndrome
